Wed, April 11, 2012
Tue, April 10, 2012
Mon, April 9, 2012
Sun, April 8, 2012
Sat, April 7, 2012
Fri, April 6, 2012
Thu, April 5, 2012
Wed, April 4, 2012
Tue, April 3, 2012

Cepheid Schedules 2012 First Quarter Financial Results Announcement and Webcast


//science-technology.news-articles.net/content/2 .. -financial-results-announcement-and-webcast.html
Published in Science and Technology on Thursday, April 5th 2012 at 13:27 GMT by Market Wire   Print publication without navigation


Cepheid Schedules 2012 First Quarter Financial Results Announcement and Webcast -- SUNNYVALE, Calif., April 5, 2012 /PRNewswire/ --

Cepheid Schedules 2012 First Quarter Financial Results Announcement and Webcast

[ ]

SUNNYVALE, Calif., April 5, 2012 /PRNewswire/ -- Cepheid (Nasdaq: [ CPHD ]) today announced that it will report financial results for its 2012 first quarter on Thursday, April 19, 2012, after the close of the market.

The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, April 19, 2012, to discuss the results.  To access the live webcast, please visit Cepheid's website at [ www.cepheid.com/investors ] at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants and investors may also listen to the live teleconference call by dialing (800) 920-8624 or (617) 597-5430, and entering participant code 71854034.  A replay will be available for seven days beginning at 4 p.m. Pacific Time.  Access numbers for this replay are (888) 286-8010 or (617) 801-6888, with passcode 29985463.

About Cepheid

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.  Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit [ http://www.cepheid.com ].

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

CONTACTS:


For Media Inquiries:

For Investor Inquiries:

Jared Tipton

Jacquie Ross

Cepheid Corporate Communications

Cepheid Investor Relations

Tel: (408) 400 8377

Tel: (408) 400 8329

[ communications@cepheid.com ]

[ investor.relations@cepheid.com ]

SOURCE Cepheid

[ Back to top ]

RELATED LINKS
[ http://www.cepheid.com ]


Publication Contributing Sources